News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022
News Daily News Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS Todd Neale December 01, 2022
News Daily News Greater Carotid Plaque Burden in Asthmatic Patients: MESA Michael O'Riordan November 24, 2022
News Daily News Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis Michael O'Riordan November 22, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2022 Shelley Wood October 03, 2022
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
News Conference News TCT 2022 RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP Todd Neale September 18, 2022
News Daily News IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document L.A. McKeown August 05, 2022
News Daily News RADIANCE II Top-Line Results Promising for Ultrasound Renal Denervation Todd Neale July 26, 2022
News Daily News Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained Yael L. Maxwell July 15, 2022
News Conference News EuroPCR 2022 Registry Data Hint at MACE Benefit With Renal Denervation Michael O'Riordan May 17, 2022
Presentation EuroPCR 2022 Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO Presenter: Ajay J. Kirtane, Michel Azizi May 17, 2022
News Daily News New CAC Risk Tool Helps Contextualize Scores for Younger Adults Yael L. Maxwell May 12, 2022
News Daily News Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions L.A. McKeown May 06, 2022
News Conference News ACC 2022 FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses Michael O'Riordan April 06, 2022
News Conference News ACC 2022 Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS Michael O'Riordan March 25, 2022